MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Study of Chemotherapy with or without Pembrolizumab in TKI-resistant EGFR-mutated Tumors in Metastatic Non-Squamous Non-small Cell Lung Cancer
3Phase III in Spain, 2Phase II, 1Phase I in Spain